Email ID
Password
Forgotten your password?
Advanced Search
Home
Companies
Patients
Investigators
Trials & Research
Regulatory
Therapeutics
Companies
LATEST NEWS
Kendle upgrades global data platform
10 March 2010
Kendle International Inc has installed a new centralised data infrastructure that it says will help improve the access and the delivery of clinical trials data for its global customers. The new system, based on the industry-standard SAS software platform, allows Kendle’s network of biostatistics ...
PPD launches global biostatistics technology infrastructure...
Quintiles adds tissue testing to China services...
PharmaNet recruits children for hayfever drug trial
09 March 2010
PharmaNet Development Group Inc is looking for children to take part in a new Phase I/II trial of the Spanish pharmaceutical company Faes Farma ’s hayfever drug, Bilastine, a novel antihistamine. The company is looking for 44 patients between the ages of two and twelve with either allergic ...
PharmaNet to host drug development symposia in three cities
09 March 2010
PharmaNet Development Group is to host a series of symposia and round-table discussions in three cities in the US on "Accelerating Early Stage Development and the FDA's Critical Path Initiative". The first two symposia will be in California, in San Francisco on the 16 March and on the following day ...
Almac honoured for contribution to Northern Irish business
09 March 2010
Almac Group, a contract development and manufacturing organisation based in Craigavon, Northern Ireland, has won an award for its "outstanding contribution to the Northern Irish economy and improving business relationships between the UK and Ireland". The annual Aer Lingus Viscount Award for ...
>> More Latest News...
FEATURES
EndPoint: Jeff Thomis
03 February 2010
Dr Jeff Thomis, PhD, is president of global clinical development services at Quintiles. He has worked at the CRO since 1997 but has held his current position, which involves selling and delivering services for Phase II-V studies, since 2006. Before Quintiles he spent 21 years at Bristol Myers ...
EndPoint: Helen Springford
25 November 2009
Helen Springford, board member of the Institute of Clinical Research and vice-president of client relations at Pharm-Olam Did you always want to work in healthcare? I knew from an early age that I wanted to work in the medical field, although as a child I had been keen to work in a mortuary and ...
EndPoint: Nicola Murgatroyd
30 October 2009
Nicola founded Phlexglobal in 1997. The CRO provides logistical, clinical and administrative support to the clinical research industry and employs up to 200 staff. Nicola has 20 years experience in the pharmaceutical industry and has been instrumental in pioneering the role of the clinical trial ...
Mega-Mergers dominate M&A in Pharma Q1
20 August 2009
Three titanic mega-mergers dominated the first three months of the year as the life sciences industry broke records for the number and the size of deals recorded during a single quarter. Largest was the US$64 billion purchase by Pfizer of its rival Wyeth, which should help it offset its inevitable ...
>> More Features...
PEOPLE
ACM appoints Asia Pacific manager
10 March 2010
ACM Global Central Laboratory has appointed a new general manager of Asia Pacific, Nandan Rao , who will spearhead the company's growth in India and Southeast Asia. His first responsibility will be to oversee trials conducted by ACM's partner laboratory, before building the company’s own local ...
Venn Life Sciences hires new VP of business development
10 March 2010
Venn Life Sciences has hired Dale Trask as vice-president of global business development. Mr Trask brings extensive experience in CRO business development and will be responsible for enhancing Venn's business partnerships, strategic relationships and growth into new markets. Mr Trask joins Venn ...
Entest Biomedical adds CRO experience to scientific board
10 March 2010
Entest BioMedical has appointed Dr Vladimir Bogin to its scientific advisory board (SAB). Dr Bogin is the CEO of CRO Cromos Pharma. The company feels the addition of Dr Bogin to the SAB will "greatly assist in developing its clinical protocols as it moves forward to conducting both preclinical and ...
>> More People...
COMMENTARY
Renal Failure: challenges and opportunities
The term renal failure describes a decline in the excretory function of the kidney due to a reduction in glomerular filtration rate. In adults, renal failure may be either acute, lasting from a few days to a few weeks, or chronic, lasting months to years. Acute renal failure is a medical ...
Filling the gaps
Most stakeholders in Europe are in favour of some form of EU centralised approval system for multinational clinical trials, with the pharmaceutical industry and the European Medicines Agency among the strongest backers for such a move. But the support is not unanimous: many national regulatory ...
The fight against malaria - all still to play for
If you didn't know, how many cases of malaria would you guess occur every year around the globe? A million? Two million? In fact, around 250 million cases of malaria occur each year. Most of these occur in developing countries, although malaria is also an issue for travellers from developed ...
UK wants harmonisation, not centralisation, of European trial approvals
The UK drug regulator, the MHRA, says it does not want a centralised approvals system for clinical trials in Europe, preferring instead the voluntary harmonisation project for authorising multinational studies that is currently being piloted in the EU. The MHRA also feels that introducing a single ...
EU promises multinational CTA harmonisation at last
The problem stems mainly from the way that the EU clinical trials Directive (2001/20/EC) has been implemented by the various member states. National authorities have different format, language and content requirements for clinical trial approvals, as well as different timelines for reviewing ...
Search continues for improved BPH treatments
The recent announcement by Boehringer Ingelheim that it plans to make the alpha blocker tamsulosin available without a prescription in the UK is a reflection of the continued interest in the benign prostatic hyperplasia (BPH) market. The condition affects some 15 million men across the seven major ...
>> More Commentary...
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Designing the Future Conditions for Clinical Research in Europe
17 March 2010
Brussels, Belgium
ICR Annual Spring Conference and Exhibition
19 April 2010
London, UK
CDISC Interchange Europe
26 April 2010
London, UK
